Immuno-Biological Laboratories (4570) · RiskMitigated
Goodwill impairment risk associated with the CURED investment
First written in FY2020. 1 of 3 entries say "Mitigated", first in FY2023-Q3. Latest entry: FY2023-Q3.
3entries
4years
0from disclosures
How it moved
Same theme, other companies
Post-M&A integration and goodwill impairment riskA theme 470 companies write about · 504 as a headwind · 1 as a tailwind
The whole theme swung hardest in 2024: 36 of 89 companies on the "Worse" side.
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 187 companies compared. The sentences above are computed from all 187.Comparing 200 of the theme's 505 threads.Full recordFilings, disclosures and news, newest first
- FY2023-Q3MitigatedAnnual report
「As the business relationship between the group and CURED Co. had become less significant, and to minimize external effects, the group decided to transfer part of its shares in CURED Co. and exclude the company from its associates accounted for under the equity method.」
A policy was decided to exclude CURED Co. from associates accounted for under the equity method through the partial transfer of its shares. The company indicated that it would reduce its equity-method exposure to the investment in and goodwill related to CURED Co. - FY2021Indications of impairment identified, but no loss recognizedAnnual report
「Investment securities (CURED Co.): ¥480.243 million」
Although the company determined that there were indications of impairment for goodwill related to CURED, it did not recognize an impairment loss in the current fiscal year because undiscounted future cash flows exceeded the carrying amount. - FY2020First statedAnnual report
「Goodwill at the company is tested for impairment at least once a year or whenever indications of impairment are identified. If the goodwill is found not to generate the required future cash flows, an impairment loss will need to be recognized.」
The company newly identified the possibility of goodwill impairment due to insufficient future cash flows as a risk for CURED, which it made an associate for the purpose of commercializing anti-HIV antibodies.